Literature DB >> 22942403

Large-joint damage in patients with early rheumatoid arthritis and its association with treatment strategy and damage of the small joints.

Linda Dirven1, Marianne van den Broek, Herman M Kroon, Bernard A M Grillet, K Huub Han, Pit J S M Kerstens, Tom W J Huizinga, Willem F Lems, Cornelia F Allaart.   

Abstract

OBJECTIVE: To determine the prevalence of large-joint damage and the association with small-joint damage in patients with RA after 8 years of low DAS (≤2.4)-targeted treatment with different treatment strategies.
METHODS: Radiological data of 290 patients participating in the BeSt study, a randomized trial comparing initial monotherapy and initial combination therapy strategies, were used. Radiographs of large joints were scored using the Larsen score and of the small joints using the Sharp-van der Heijde score. With multivariate logistic regression analysis, an association between total damage of the small joints and of the large joints was investigated.
RESULTS: After 8 years of treatment, damage was observed in 12% of shoulders, 10% of elbows, 26% of wrists, 13% of hips, 18% of knees and 7% of the ankles. Damage in one or more large joints was found in 64% of patients, with a median score of 1. No difference was found between initial monotherapy or combination therapy strategies. There was a significant association between damage progression in small joints and damage to one or more large joints (OR 1.02; 95% CI 1.00-1.04).
CONCLUSION: After 8 years of DAS-targeted treatment in early RA patients, large-joint damage was found in 64% of patients and was associated with small-joint damage. Continued DAS-targeted treatment is probably more important in damage suppression than initial treatment strategy. Patients with more damage to hands and feet also have more damage to the large joints.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22942403     DOI: 10.1093/rheumatology/kes228

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  3 in total

1.  Identification of poor prognostic joint locations in an early rheumatoid arthritis cohort at risk of rapidly progressing disease: a post-hoc analysis of the Phase III AGREE study.

Authors:  Patrick Durez; Rene Westhovens; Femke Baeke; Yedid Elbez; Sofie Robert; Harris A Ahmad
Journal:  BMC Rheumatol       Date:  2022-04-14

2.  MRI-detected synovitis of the small joints predicts rheumatoid arthritis development in large joint undifferentiated inflammatory arthritis.

Authors:  Navkiran Sidhu; Fenne Wouters; Ellis Niemantsverdriet; Annette H M van der Helm-van Mil
Journal:  Rheumatology (Oxford)       Date:  2022-04-18       Impact factor: 7.046

3.  Change of ARASHI scores for large joints in rheumatoid arthritis patients treated with abatacept for three years: A clinical observational study.

Authors:  Takeshi Mochizuki; Koichiro Yano; Katsunori Ikari; Ryo Hiroshima; Mina Ishibashi; Ken Okazaki
Journal:  Arch Rheumatol       Date:  2020-06-25       Impact factor: 1.472

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.